Retrospective analysis of a group of patients with advanced Non-Small-Cell lung cancer (NSCLC) treated with Gefitinib

被引：0
|
作者：
Bandera, M. [1 ]
Bascialla, L. [1 ]
Martinelli, B. [1 ]
Masera, G. L. Rodolfo [1 ]
Vallini, I. [1 ]
Zanlorenzi, L. [1 ]
Pinotti, G. [1 ]
机构：
[1] Osped Circolo & Fondazione Macchi, UO Oncol Med, Varese, Italy
来源：
ANNALS OF ONCOLOGY | 2005年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：25 / 25
页数：1
相关论文
共 50 条
  • [31] Gefitinib: A new antineoplastic for advanced non-small-cell lung cancer
    Cersosimo, RJ
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2004, 61 (09) : 889 - 898
  • [32] Non-small-cell lung cancer (NSCLC) treated with chemotherapy: Survival analysis of 50 patients
    Flores, MM
    Murillo, SM
    Alonso, EG
    Gilart, AB
    CarcellerVidal, JA
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1088 - 1088
  • [33] CT findings in non-small-cell lung cancer patients treated with gefitinib or erlotinib
    Na, Im Il
    Choe, Du Hwan
    Kim, Cheol Hyeon
    Park, Sun Hoo
    Park, Jong Heon
    Lee, Jae Cheol
    [J]. JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2012, 8 (02) : 247 - 253
  • [34] Gefitinib in elderly and unfit patients affected by advanced non-small-cell lung cancer
    Gridelli, C
    Maione, P
    Castaldo, V
    Rossi, A
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 (10) : 1827 - 1829
  • [35] Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer
    De Braud, F
    De Pas, T
    Spaggiari, L
    Veronesi, G
    Curigliano, G
    Noberasco, C
    Pelosi, G
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (06) : 461 - 462
  • [36] Gefitinib in the treatment of elderly patients with advanced non-small cell lung cancer (NSCLC)
    Bearz, Alessandra
    Fratino, Lucia
    Spazzapan, Simon
    Berretta, Massimiliano
    Giacalone, Annalisa
    Simonelli, Cecilia
    Tirelli, Umberto
    [J]. LUNG CANCER, 2007, 55 (01) : 125 - 127
  • [37] Serum EGFR in patients with non-small cell lung cancer (NSCLC) treated with gefitinib
    Spreafico, A
    Gregorc, V
    Ludovini, V
    Pistola, L
    Amoroso, M
    Tofanetti, F
    Compagnoni, A
    Aondio, G
    Tonato, M
    Villa, E
    [J]. LUNG CANCER, 2005, 49 : S112 - S113
  • [38] RETROSPECTIVE ANALYSIS OF CLINICAL FEATURES OF 5-YEAR-SURVIVAL PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG CANCER (NSCLC)
    Hirashima, T.
    Okamoto, N.
    Suzuki, H.
    Morishita, N.
    Tamiya, M.
    Shiroyama, T.
    Kondoh, Y.
    Ryota, N.
    Kawase, I.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 113 - 113
  • [39] PHARMACOGENETIC STUDY IN PATIENTS WITH ADVANCED NON-SQUAMOUS NON-SMALL-CELL LUNG CANCER (NSCLC) TREATED WITH PEMETREXED
    Yasue, T.
    Hirashima, T.
    Kobayashi, M.
    Okamoto, N.
    Suzuki, H.
    Hosono, K.
    Morishita, N.
    Matsuura, Y.
    Tamiya, M.
    Shiroyama, T.
    Morita, S.
    Matsumoto, T.
    Morishita, H.
    Kawahara, K.
    Kawase, I.
    [J]. ANNALS OF ONCOLOGY, 2012, 23 : 136 - 136
  • [40] Gefitinib (G) treatment outcome after progression on erlotinib (E) in patients with advanced non-small-cell lung cancer (NSCLC)
    Grossi, F.
    Brianti, A.
    Defferrari, C.
    Dal Bello, M. G.
    Loprevite, M.
    Catania, G.
    Pronzato, P.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 395 - 395
12345